METHODS
The PDD and lateral dose profiles were measured for open fields with sizes from 4×4 cm2 to 28×28 cm2
in a water tank using a semiflex ionization chamber. The PDD and profiles were calculated with the
AAA v17.1 in Eclipse for the same field sizes as described in ion chamber measurements. The depth of
maximum dose (dmax), PDD value at depth of 10 cm, penumbra, field size, and lateral distance from the
central axis at 90%, 75%, and 60% dose points of profile were analyzed.
RESULTS
The difference of dmax values was 0.08 cm for all PDDs. A good agreement was obtained between calculated
and measured PDD10 with a maximum difference of 0.35%. The measured field size and penumbra
values indicated an excellent agreement with calculated values with a maximal discrepancy of 0.17
cm and 0.50 mm for all field sizes, respectively. The discrepancies between calculated and measured
lateral distances for all field sizes were within 0.20 mm.
CONCLUSION
The TPS-calculated data using pre-configured beam model for Halcyon 3.0 were in good agreement
with the measurements.
Keywords: Beam data verification; golden beam data; halcyon; TPS verification
The installation and commissioning of the Halcyon
can be performed rapidly because the manufacturer
offers reference beam data (RBD) set including
the percentage depth dose (PDD), lateral dose profiles,
output factors, and pre-defined beam model in
the Eclipse treatment planning system (TPS) (Varian
Medical Systems, Palo Alto, CA).[
Measurements
A PTW MP3-M water tank (PTW-Freiburg, Germany)
and a semiflex 0.125 cm3 ionization chamber
(type 31010, PTW-Freiburg, Germany) were used
for all beam data measurements. The PDD and lateral
dose profiles were obtained for open fields with
sizes from 4×4 cm2 to 28×28 cm2 determined by MLC
settings. The SSD was set to 100 cm. The lateral dose
profiles were measured at a depth of 10 cm under the
same setup conditions. All data were smoothed and
normalized to maximum value for each PDD curve.
The normalization was conducted to the central-axis
value for each profile. The beam data analysis was performed
with Mephysto mc2 software.
Calculations
Analysis
The field width and penumbra were analyzed under
profiles. Usually, the radiation field size of FF photon
beams is specified at 50% of the isodose level of profile.
This definition cannot be implemented for the field size
of FFF photon beams because the 50% isodose level occurs
at the high dose gradient part of the profile. The determination
of the field size and penumbra was carried
out according to the Atomic Energy Regulatory Board
of India Task Group (AERB-TG) recommendations.[
The inflection point (IP) is defined as the midpoint
on either side of the high gradient region (sharply de scending part) of the beam profile. The starting point
(S) and ending point (E) of the high gradient region of
the beam profile are identified. The vertical separation
between S and E is the height (h) of the high gradient region
of the beam profile. The point at h/2 is considered
as the point of inflection. The lateral separation between
left and right IP (IPL and IPR) along the central axis is
taken as field width. For determining penumbra, dose
value at IP was taken as reference dose value (RDV).
Points Pa and Pb are located at 1.6 and 0.4 times of RDV,
respectively. Lateral separation between Pa and Pb on
either side of the profile is measured as penumbra.[
The measurements were made using 6 MV-FFF photon
beams by utilizing the Varian Halcyon v3.0 system.
The output of the machine was calibrated to deliver 1
cGy/MU under reference conditions; source to skin
distance (SSD)=100 cm, field size = 10×10 cm2, and at
depth=dmax (1.3 cm). Before measuring the beam data,
the output of the machine was checked using RW3 water-
equivalent slab phantom and a 0.6 cc farmer-type
ionization chamber according to the TRS-398.[
Vendor provides RBD set and configures dose calculation
models using these data in Eclipse TPS. In this
study, the virtual water phantom with size of 40×40×40
cm3 was created in Varian Eclipse v17.1 TPS (Varian
Medical Systems, Palo Alto, CA). The PDD and profiles
were calculated with the AAA v17.1 algorithm for the
same field sizes as described in ion chamber measurements.
The dose for each calculation was set at 100 MU.
The calculation grid size was 2.5 mm. The PDDs were
normalized to their maximum values for each field
size. The profiles were normalized to the corresponding
central axis value for each field size.
The calculated dose distribution with AAA algorithm
for PDD and profiles were compared with our measurements.
The PDD value at 10 cm (PDD10), which is
beam quality specifier according to TG-51, and depth
of dose maximum (dmax) were recorded.
RDV: Reference dose value
PDD: Percentage depth dose
The normalized central axis lateral dose profiles
are measured and calculated for each field size at depth of 10 cm are shown in Figure
The comparison was made between the calculated PDDs and profiles with AAA v17.1 in TPS and the measured data with a semiflex ionization chamber in Halcyon v3.0 for field size ranging 4×4 cm2 to 28×28 cm2. This study reported that the measured data indicated an excellent agreement with the Eclipse TPS calculated data. As expected, the main dose differences are in surface dose in PDDs for all field sizes because TPSs cannot calculate the surface dose accurately.[10]
Netherton et al.[
Tamura et al.[
Pathak et al.[
The above-mentioned studies are compatible with
our study results which showed an excellent agreement
between measured data and TPS calculated data using
on pre-installed beam model for Halcyon v3.0. The penumbra
values were found to be 3.92 and 8.27 mm from
measured profiles for 4×4 cm2 and 28×28 cm2, respectively.
The measured penumbra widths matched the calculated
penumbra widths with a maximum difference
of 0.5 mm for all field sizes at a depth of 10 cm. The
measured PDD10 was 62.90% for 10×10cm2 at SSD=100
cm, with a 0.16% discrepancy from calculated one (Varian
specification 63%±1). The TPR20,10 was found to be
0.620 in our study which is consistent with the previous
published study.[
Peer-review: Externally peer-reviewed.
Conflict of Interest: All authors declared no conflict of interest.
Ethics Committee Approval: The study was approved by the Academic Coordination Community of Istanbul University Institute of Oncology (no: 2065990, date: 24/08/2023).
Financial Support: None declared.